Synedica Retatrutide

Synedica

£220.00

Retatrutide is classified as a triple agonist, meaning it targets three key hormone receptors: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors. By stimulating all three, Retatrutide enhances insulin sensitivity, suppresses appetite, increases energy expenditure, and improves blood sugar control.

3 in stock
  Buy NOW
We offer:
We offer PayPal

Retatrutide is designed as a multi-agonist targeting multiple hormone receptors involved in glucose regulation and appetite control.

Retatrutide acts on glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors, aiming to improve blood sugar control, reduce body weight, and enhance overall metabolic health. 

Box comes with x1 pen (40mg) and 12 pins 

For research purposes only and not for human consumption.

0
Shopping Basket
X